Endemicity of Acinetobacter calcoaceticus-baumannii Complex in an Intensive Care Unit in Malaysia

Journal of Pathogens
Amreeta DhanoaKwai Lin Thong

Abstract

Introduction. Acinetobacter calcoaceticus-baumannii complex (ACB complex) is a leading opportunistic pathogen in intensive care units (ICUs). Effective control of spread requires understanding of its epidemiological relatedness. This study aims to determine the genetic relatedness and antibiotic susceptibilities of ACB complex in an ICU in Malaysia. Methodology. Pulsed field gel electrophoresis (PFGE), E-test, and disk diffusion were used for isolates characterization. Results. During the study period (December 2011 to June 2012), 1023 patients were admitted to the ICU and 44 ACB complex (blood, n = 21, and blind bronchial aspirates, n = 23) were recovered from 38 ICU patients. Six isolates were from non-ICU patients. Of the 44 ICU isolates, 88.6% exhibited multidrug-resistant (MDR) patterns. There was high degree of resistance, with minimum inhibitory concentration90 (MIC90) of >32 μg/mL for carbapenems and ≥256 μg/mL for amikacin, ampicillin/sulbactam, and cefoperazone/sulbactam. Isolates from the main PFGE cluster were highly resistant. There was evidence of dissemination in non-ICU wards. Conclusion. High number of clonally related MDR ACB complex was found. While the ICU is a likely reservoir facilitating transmission, imp...Continue Reading

References

Aug 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·X CorbellaF Gudiol
Feb 24, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M L LingG C Wang
Oct 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M-L Joly-Guillou
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mark WilksMichael R Millar
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Apr 19, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Antonios MarkogiannakisAthanassios Tsakris
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Aug 5, 2008·American Journal of Infection Control·Raquel Eve BarbollaMariana Catalano
Aug 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anucha ApisarnthanarakUNKNOWN Thammasat University Pandrug-Resistant Acinetobacter baumannii Control Group
Nov 22, 2008·The Lancet Infectious Diseases·Drosos E Karageorgopoulos, Matthew E Falagas
Dec 24, 2010·Journal of Clinical Microbiology·Pilar VillalónJuan A Saez-Nieto
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Sep 17, 2011·American Journal of Respiratory and Critical Care Medicine·Doo Ryeon ChungUNKNOWN Asian Network for Surveillance of Resistant Pathogens Study Group
Jun 15, 2012·The New England Journal of Medicine·Claudio U KöserSharon J Peacock
Aug 24, 2012·Science Translational Medicine·Evan S SnitkinJulia A Segre

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
genotyping

Software Mentioned

BioNumerics

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.